Literature DB >> 31494796

Inhibiting microRNA-7 Expression Exhibited a Protective Effect on Intestinal Mucosal Injury in TNBS-Induced Inflammatory Bowel Disease Animal Model.

Jing Guo1, Li-Juan Yang2, Mei Sun1, Ling-Fen Xu3.   

Abstract

This study aimed to explore the expression and correlation of microRNA-7 (miR-7) and trefoil factor 3 (TFF3) genes and proteins in inflammatory bowel disease (IBD) mouse models and to elucidate the effect of miR-7 inhibition in the intestinal mucosa in IBD models. A TNBS-induced IBD mouse model was established. Changes in intestinal inflammation were observed by HE staining, and the expression levels of miR-7 and TFF3 were detected by RT-PCR. After miRNA-antagomir injection, the degree of colonic tissue damage and the expression levels of miR-7 and TFF3 in intestinal tissues were compared. TNBS-induced IBD mice showed significant weight loss, significantly decreased disease activity index (DAI), and a significantly increased pathological damage score. miR-7 was highly expressed in the colon tissue of IBD mice, and TFF3 was downregulated. Inhibition of the expression of miR-7 improved the stool characteristics and fecal occult blood (OB) of IBD mice, significantly increased the expression of TFF3 protein, and decreased the pathological damage scores. In the IBD mouse model, miR-7 posttranscriptionally regulates TFF3. The inhibition of miR-7 expression improves some clinical manifestations of IBD mice, reduces the pathological damage of the intestinal mucosa, and shows a protective effect in IBD.

Entities:  

Keywords:  inflammatory bowel disease; miRNA antagomir; microRNA-7; trefoil factor 3

Mesh:

Substances:

Year:  2019        PMID: 31494796     DOI: 10.1007/s10753-019-01091-1

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.657


  17 in total

1.  A new model of chronic hapten-induced colitis in young rats.

Authors:  Leo R Fitzpatrick; Katia Meirelles; Jeffrey S Small; Frances J Puleo; Walter A Koltun; Robert N Cooney
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-03       Impact factor: 2.839

2.  Quantitative analysis reveals differential expression of mucin (MUC2) and intestinal trefoil factor mRNAs along the longitudinal axis of rat intestine.

Authors:  Y Matsuoka; J C Pascall; K D Brown
Journal:  Biochim Biophys Acta       Date:  1999-12-23

3.  MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.

Authors:  YuXiang Fang; Jing-Lun Xue; Qi Shen; Jinzhong Chen; Ling Tian
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

Review 4.  microRNA regulation of inflammatory responses.

Authors:  Ryan M O'Connell; Dinesh S Rao; David Baltimore
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

5.  The rising incidence of paediatric-onset inflammatory bowel disease.

Authors:  Paul Henderson; David C Wilson
Journal:  Arch Dis Child       Date:  2012-07       Impact factor: 3.791

6.  Effects of trefoil peptide 3 on expression of TNF-alpha, TLR4, and NF-kappaB in trinitrobenzene sulphonic acid induced colitis mice.

Authors:  Xu Teng; Ling-Fen Xu; Ping Zhou; Hong-Wei Sun; Mei Sun
Journal:  Inflammation       Date:  2009-04       Impact factor: 4.092

7.  Most mammalian mRNAs are conserved targets of microRNAs.

Authors:  Robin C Friedman; Kyle Kai-How Farh; Christopher B Burge; David P Bartel
Journal:  Genome Res       Date:  2008-10-27       Impact factor: 9.043

8.  Inflammatory bowel disease in Chinese children: a multicenter analysis over a decade from Shanghai.

Authors:  Xin-qiong Wang; Yin Zhang; Chun-di Xu; Li-rong Jiang; Ying Huang; Hui-min Du; Xiao-jin Wang
Journal:  Inflamm Bowel Dis       Date:  2013-02       Impact factor: 5.325

Review 9.  MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics.

Authors:  Mehmet Coskun; Jacob Tveiten Bjerrum; Jakob Benedict Seidelin; Ole Haagen Nielsen
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

10.  Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis.

Authors:  Manirath Khounlotham; Wooki Kim; Eric Peatman; Porfirio Nava; Oscar Medina-Contreras; Caroline Addis; Stefan Koch; Benedicte Fournier; Asma Nusrat; Timothy L Denning; Charles A Parkos
Journal:  Immunity       Date:  2012-09-13       Impact factor: 31.745

View more
  7 in total

1.  The Anti-Inflammatory Immune Response in Early Trichinella spiralis Intestinal Infection Depends on Serine Protease Inhibitor-Mediated Alternative Activation of Macrophages.

Authors:  Ning Xu; Xue Bai; Yan Liu; Yaming Yang; Bin Tang; Hai Ning Shi; Isabelle Vallee; Pascal Boireau; Xiaolei Liu; Mingyuan Liu
Journal:  J Immunol       Date:  2021-01-25       Impact factor: 5.422

2.  Exploring the wound healing, anti-inflammatory, anti-pathogenic and proteomic effects of lactic acid bacteria on keratinocytes.

Authors:  Jessica Brandi; Samuele Cheri; Marcello Manfredi; Claudia Di Carlo; Virginia Vita Vanella; Federica Federici; Eleonora Bombiero; Alda Bazaj; Eleonora Rizzi; Laura Manna; Giuseppe Cornaglia; Umberto Marini; Maria Teresa Valenti; Emilio Marengo; Daniela Cecconi
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.379

Review 3.  Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models.

Authors:  Kanika Suri; Jason A Bubier; Michael V Wiles; Leonard D Shultz; Mansoor M Amiji; Vishnu Hosur
Journal:  Cells       Date:  2021-08-26       Impact factor: 7.666

4.  Moxibustion Inhibits the Expression of Colonic NLRP3 through miR7/RNF183/NF-κB Signaling Pathway in UC Rats.

Authors:  Xi-Ying Li; Yan-Ting Yang; Yue Zhao; Xie-He Kong; Guang Yang; Jue Hong; Dan Zhang; Xiao-Peng Ma
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-03       Impact factor: 2.629

5.  Immune-related biomarkers shared by inflammatory bowel disease and liver cancer.

Authors:  Thong Ba Nguyen; Duy Ngoc Do; Thuy T P Nguyen; Truc Ly Nguyen; Tung Nguyen-Thanh; Ha Thi Nguyen
Journal:  PLoS One       Date:  2022-04-22       Impact factor: 3.752

6.  Aryl hydrocarbon receptor activation ameliorates experimental colitis by modulating the tolerogenic dendritic and regulatory T cell formation.

Authors:  Xiufang Cui; Ziping Ye; Di Wang; Yan Yang; ChunHua Jiao; Jingjing Ma; Nana Tang; Hongjie Zhang
Journal:  Cell Biosci       Date:  2022-04-23       Impact factor: 9.584

7.  Protection by microRNA-7a-5p Antagomir Against Intestinal Mucosal Injury Related to the JNK Pathway in TNBS-Induced Experimental Colitis.

Authors:  Bao Yin; Huang Tian-Chu; Xu Ling-Fen
Journal:  Turk J Gastroenterol       Date:  2021-05       Impact factor: 1.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.